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Volume of Carotid Artery Ulceration as a Predictor
of Cardiovascular Events
Mariya Kuk; Thapat Wannarong, MD; Vadim Beletsky, MD; Grace Parraga, PhD;
Aaron Fenster, PhD; J. David Spence, MD
Background and Purpose—Previous studies have shown the presence of ulceration in atherosclerotic plaque either by
categorizing the plaque as complex (irregular morphology with ulcers) or smooth or by quantifying the number of ulcers
observed in a specific region of interest. The aim of this study was to quantify carotid total ulcer volume by 3-dimensional
ultrasound to investigate the relationship of total ulcer volume to vascular events (strokes, transient ischemic attack,
myocardial infarction, revascularization, or death because of cardiovascular reasons).
Methods—In total, 349 at-risk subjects provided written informed consent to carotid 3-dimensional ultrasound and
were analyzed for ulcerations. Ulcer volume was defined as a distinct discontinuity in an atherosclerotic plaque, with
a volume ≥1.00 mm3 as measured using manual segmentation. The sum of the volumes of all ulcers seen in both
carotids was the total ulcer volume. Participants were monitored for ≤5 years for outcomes, including cardiovascular
events and death.
Results—Kaplan–Meier survival analysis showed that subjects with total ulcer volume ≥5 mm3 experienced a significantly
higher risk of developing stroke, transient ischemic attack, or death (P=0.009) and of developing stroke/transient
ischemic attack/death/myocardial infarction/revascularization (P=0.017). Lower ulcer volumes did not predict events
nor did ulcer depth.
Conclusions—Volume of carotid ulceration on 3-dimensional ultrasound predicts cardiovascular events. In addition to
improving risk stratification, ulceration is a potential therapeutic target.   (Stroke. 2014;45:1437-1441.)
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Methods

lceration of carotid atherosclerotic plaques has been
associated with plaque rupture, intraplaque hemorrhage,1
larger lipid core, and decreased amounts of fibrous tissue1 and
decreased stability.1,2 Ulceration tends to be associated with
greater plaque thickness and plaque volume.2,3
Plaque morphology has been previously assessed with the
use of ultrasound imaging. Previous studies have categorized
plaque as having an irregular or smooth morphology and
found that irregularity of plaque significantly increased the
risk of stroke.4 Other studies, specifically focusing on ulcerations, also noted the increased risk in stroke development
with ulcerated plaques.5–7
Our group reported previously that ulcer number (≥3 ulcers
when both left and right carotid arteries are combined) predicted stroke, transient ischemic attack (TIA), or death.7 The
aim of the current study is to determine whether total ulcer volume (TUV) identifies high-risk patients with atherosclerosis.

Study Population
As described previously,8 participants were patients attending the
Stroke Prevention and Atherosclerosis Center clinic at London
Ontario, Canada, who volunteered for a carotid imaging study funded by the Heart and Stroke Foundation of Canada. They had been
referred to the Hypertension Clinic, the Premature Atherosclerosis
Clinic, or the Stroke Prevention Clinic. All had been monitored annually with carotid duplex ultrasound, including measurement of total
plaque area. Patients were eligible if their total plaque area was in the
top tertile among the patient populations (40–600 mm2), representing
moderate-to-severe atherosclerosis. Hypertension was defined as on
antihypertensive medication or a baseline blood pressure <140 systolic or 90 diastolic; diabetes mellitus was defined as on medication
for diabetes mellitus; dyslipidemic was defined as on lipid-lowering
medication. In total, 349 patients were enrolled in the study and
consented to a protocol approved by the Western University Human
Ethics Research board, approval number 12401E. The participants
were followed up for ≤5 years.
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Medical Therapy
All the participants received standard intensive medical therapy that
is routine in our clinic, as previously described.9 This included advice
on smoking cessation, maintenance of a healthy weight, exercise,
moderate alcohol consumption, blood pressure control, lipid-lowering therapy, and antiplatelet therapy or anticoagulation, as appropriate. There was no alteration of therapy based on ulcer volumes.

Total Plaque Area
Carotid plaque burden, a strong predictor of cardiovascular risk,10–14
was measured as previously described10 by tracing with a cursor the
area of every plaque seen in the internal, external, and common carotid arteries on both sides in the plane of the longitudinal view in
which the plaque was biggest. The sum of all plaque areas was the
total plaque area.

Ascertainment of Outcomes
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At each annual visit, the participants self-reported any events that
occurred during the previous year; these were verified in hospital
records. Events included stroke, TIA, revascularization (stenting, bypass, or endarterectomy of any artery), or death. Cause of death was
confirmed by the primary care physician.
A TIA was defined as an episode of focal neurological symptoms diagnosed by a stroke neurologist as being caused by cerebral
ischemia, with symptoms persisting <24 hours and no corresponding lesion seen on brain imaging. A stroke was an episode of focal
neurological dysfunction caused by cerebral ischemia, with symptoms and signs persisting >24 hours, or symptoms and signs persisting <24 hours, and a corresponding lesion seen on brain imaging.
Vascular death was defined as death because of stroke, myocardial
infarction (MI), aortic dissection, or vascular surgery/intervention.
Revascularization was a carotid endarterectomy or stenting, coronary bypass or stenting, or bypass or stenting of the aorta or a peripheral artery.
The primary outcome was a combination of stroke, TIA, or vascular death; for the survival analyses, the first event in each patient was
used to determine event-free survival. A secondary outcome was a
combination of stroke, TIA, vascular death, MI, or revascularization
(carotid, coronary, or peripheral); again, the first event in each patient
was used in survival analyses.

Ulcer Identification and Measurement of Ulcer
Depth and Ulcer Volume
A 3-dimensional (3D) scanning system was used to generate the 3D
ultrasound images of the left and right carotid arteries of patients recruited for the study as described previously.5,10 Both carotid arteries were scanned for a length of 4 cm, centered at the bifurcation.
As previously described,5 we defined an ulcer as being a continuous
and distinct depression into the atherosclerotic plaque with diameter
≥1.00 mm and depth ≥1.00 mm, with a volume ≥1.00 mm3.
Ulcer depth was measured from a contour matching the endothelial
surface on either side of the ulcer to the depth of the ulcer, at points
along the width of the ulcer (Figure 1). Maximum ulcer depth was
the greatest depth for the deepest ulcer in each case with ulceration.
Manual segmentation was used to measure the volume of each
ulcer. On identification of a distinct, continuous depression in the
plaque, the observer identified the point at which the depression began and started the initial volume measurement by tracing the contour
of the depression in a cross-sectional slice. The contours were traced
in magnified views at intervals of 0.1 mm between the frames until
the depression was no longer visible in the plaque. The slices had
a thickness of 1 mm, and the volume was computed by the sum of
area×thickness for all slices of each ulcer traced (Figure 2). A participant was considered to have no ulcerations when there was no depression in the carotid artery plaque ≥1.00 mm3. The sum of the volumes
of all ulcers seen in both carotids was TUV.

Reliability of Measurement of TUV
Intraobserver and interobserver reliability of repeat measurement
of ulcer volume was computed on 50 randomized images before
the beginning of the study using IBM SPSS version 20 software.
Intraobserver reliability was assessed for 1 blinded observer (M.K.),
and the interobserver reliability was determined by comparing measurements made independently by 2 blinded observers (M.K. and
T.W.). The intraclass correlation coefficient was 0.72 for the intraobserver reliability, and the intraclass correlation coefficient for interobserver reliability was 0.84 using average measures.

Statistical Analysis
Kaplan–Meier survival analysis with log-rank pooled over strata
function was used to analyze differences in event-free survival time

Figure 1. Measurement of ulcer volume and ulcer
depth. Contours of ulcers were traced and depth
of ulcers measured in cross-sectional views. Each
slice had a thickness of 1 mm; ulcer volume was
computed from the sum of the volumes of all slices
in which ulceration was traced (Figure I in the
online-only Data Supplement).
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Table 1.

Baseline Variables by Ulcer Volume Categories

Baseline Variable

Ulcer Volume
<5 mm3
(n=303)

Ulcer Volume
≥5 mm3
(n=19)

P
Value*
0.18

Continuous variables: mean±SD
 Age, y

Figure 2. Distribution of total ulcer volume by ulcer number. The
number of ulcers ranged from 0 to 4; total ulcer volume ranged
from 1.01 to 12.35 mm3; total ulcer volume and ulcer number
overlapped considerably.

between participants with a TUV <5.00 versus ≥5.00 mm3. When
multiple events occurred in a single participant, the time to the first
event was counted in the Kaplan–Meier survival analysis.

69.88±8.65

72.68±10.55

 Ulcer volume, mm3

0.81±1.25

7.15±2.04

0.0001

 Ulcer number

0.42±0.63

2.42±0.77

0.0001

 Systolic blood pressure, mm Hg

134±20

138±21

0.40

 Diastolic blood pressure, mm Hg

76±13

75±9

0.73

 Total cholesterol, mmol/L

4.12±1.01

4.23±1.35

0.64

 Triglycerides, mmol/L

1.39±0.78

1.39±0.79

0.98

 HDL cholesterol, mmol/L

1.40±0.44

1.43±0.42

0.83

 LDL cholesterol, mmol/L

2.13±0.95

2.22±1.08

0.69

 Homocysteine, μmol/L

9.60±4.11

10.25±4.11

0.76

 Smoking, pack-years

14.82±20.54

17.82±16.03

0.54

 Total plaque area, mm

2

 Maximal stenosis, %†

44.81±14.31

45.26±17.11

0.90

 Sex (male)

57.1%

63.2%

0.39

 Diabetic

21.8%

10.5%

0.194

9.6%

21.1%

0.025

 ACE inhibitor

49.3%

52.6%

0.48

Categorical variables, %

 Still smoking

Results
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Of the 349 patients initially recruited to the study, 313 had 3D
ultrasound scans that were technically adequate for measurement of total plaque volume. Results are presented for those
cases. Mean age was 70.05±8.77 (SD) years, 57.5% were
men, 80% were hypertensive, and 76% had dyslipidemia.
There were 26 patients with stenosis of 1 carotid between
70% and 90% and 1 patient with 1 occluded carotid artery.
Patients with carotid stenosis ≥70% did not have significantly higher TUV (P=0.13) or total ulcer number (P=0.12)
Previous history of the participants before enrollment in the
study included stroke in 22.7%, TIA in 44.1%, coronary
bypass in 10.6%, and MI in 16.1%; 21.8% had diabetes mellitus, 10.2% still smoked, 53.1% quit smoking, and 36.6%
had never smoked. Carotid stenosis of 50% to 69% was present in 29.9% of cases.
One or more carotid ulcers were present in 124 participants.
Of those with ulceration, TUV was 1.00 to 1.99 mm3 in 46,
2.00 to 2.99 mm3 in 34, 3.00 to 3.99 mm3 in 18, 4.00 to 4.99
mm3 in 7, and > 5.0 mm3 in 19. Mean TUV was 3.03 (range,
1.01–12.35) mm3. Figure 2 shows the distribution of TUV by
number of ulcers in a given participant. Baseline variables for
the 2 groups of patients (ulcer volume <5 versus ≥5 mm3) and
medications being taken at baseline and at the first follow-up
visit are shown in Table 1. Patients with >5 mm3 of ulcer volume had a higher number of ulcers, had higher total plaque
area, were more likely to be smokers, and were more likely
to be taking anticoagulants; no other variable was significant.
The median duration of patient follow-up was 3.17 years
(range, 0.07–5 years; mean, 1024 days; SD, 313 days). There
were complete data available on ulcer volume and survival in
313 of the 322 participants with measurement of ulcer volume. Among them, 10 had stroke, 13 had TIA, 5 had MI, 15
had revascularization procedure, and 13 died (4 deaths were

166.73±80.97 266.21±125.93 0.0001

Medication at baseline
 Antiplatelet agent

79.3%

63.2%

0.09

 Statin

85.7%

89.5%

0.48

 Anticoagulant

10.5%

35.6%

0.016

Medication at first follow-up visit
 ACE inhibitor

50.3%

57.9%

0.35

 Antiplatelet agent

79.2%

68.4%

0.20

 Statin

89.9%

94.7%

0.43

 Anticoagulant

10.1%

26.3%

0.046

ACE indicates angiotensin-converting enzyme; HDL, high-density lipoprotein;
and LDL, low-density lipoprotein.
*ANOVA for continuous variables, exact χ2 for categorical variables.
†Internal carotid stenosis on the side with the higher percent stenosis.

vascular, 3 died from cancer, and 6 died from other causes).
Overall, there were 59 events that occurred in 49 patients.
First event included the following: 13 revascularization
events, 11 TIA, 5 MI, 10 strokes, 4 cardiovascular deaths, and
6 noncardiovascular deaths (2 because of cancer, 4 because of
other causes). Secondary events occurred in 6 patients; these
included 2 TIA, 2 strokes, 2 revascularization events, 2 deaths:
1 because of cancer and 1 of unknown cause. One person had a
second recurrent TIA after having a stroke followed by the secondary TIA (thus stroke was the primary event and there were 2
TIAs afterward). Another patient, after having an MI as the initial event, died after revascularization from an unknown cause.
Table 2 shows the distribution of events by the 2 categories of ulcer volume. Figure II in the online-only Data
Supplement shows the relationship of total plaque area to
total plaque volume.
Event-free survival free of stroke, TIA, or death was significantly worse in patients with TUV ≥5 mm3 (log-rank
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Table 2. Distribution of First Events by the 2 Categories of
Total Ulcer Volume
Total Ulcer Volume
<5 mm3
(n=303)

≥5 mm3
(n=19)

Transient ischemic attack

9 (3%)

2 (10.5%)

Stroke

9 (3%)

1 (5.3%)

Myocardial infarction

5 (1.7%)

0

11 (3.6%)

2 (10.5%)

4 (1.3%)

0

38 (12.5%)

5 (26.3%)

5 (1.7%)

1 (5.3%)

43 (14.2%)

6 (31.6%)

Revascularization
Vascular death
Total vascular events
Nonvascular death
Total events

P=0.009; Figure 3); for survival free of stroke, TIA, death, MI,
or revascularization, the log-rank P value was 0.017. In sensitivity analyses, ulcer volumes <5 mm3 did not significantly
predict events. At a cutoff of 3 mm3, the log-rank P value for
stroke, TIA, or death was 0.80 (Figure III in the online-only
Data Supplement).
Maximum ulcer depth ranged from 0.7 to 2.7 mm (mean,
0.53+0.70 mm). Ulcer depth did not predict events (Figure IV
in the online-only Data Supplement).

Discussion
Downloaded from http://ahajournals.org by on March 3, 2020

In the North American Symptomatic Carotid Endarterectomy
Trial (NASCET), the presence of angiographically identified
ulcers was associated with a clinically important increase in
risk: “The risk of ipsilateral stroke at 24 months for medically treated patients with ulcerated plaques increased incrementally from 26.3% to 73.2% as the degree of stenosis
increased from 75% to 95%. For patients with no ulcer, the

risk of stroke remained constant at 21.3% for all degrees of
stenosis. The net result yielded relative risks of stroke (ulcer
versus no ulcer) ranging from 1.24 (95% confidence interval,
0.61–2.52) to 3.43 (95% confidence interval, 1.49–7.88).”6
However, angiography was not sensitive or specific for the
detection of ulceration identified in surgical specimens:
“Sensitivity and specificity of detecting ulcerated plaques
were 45.9% and 74.1%, respectively. The positive predictive
value of identifying an ulcer was 71.8%.”15 Fisher et al16 found
that histologically validated ulceration was more common in
endarterectomy specimens from patients with symptomatic
carotid stenosis versus asymptomatic stenosis. De Bray et al17
found that the reproducibility of detection of ulceration by 2D
ultrasound was only 0.41. Schminke et al5 reported that they
could reliably follow progression or regression of ulceration
by 3D ultrasound.
Our findings also indicate that the volume of ulceration can
be measured reliably and that ulcer volume identifies patients
at risk of cardiovascular events. We found that the volume of
carotid plaque ulceration measured by 3D carotid ultrasound
imaging predicted risk of stroke, TIA, or death and the risk of
stroke/TIA/death/MI/revascularization. These findings are in
agreement with previously reported studies showing that irregular and ulcerated plaques were associated with an increased
risk of stroke.5,8,9 This study is unique in that it assessed the
volume of ulceration as a predictor of vascular events.
Some readers may be surprised to see an ulcer dimension
as high as 5 mm3. However, this did not represent ulcer depth.
Figure 2 shows that among patients with only 1 ulcer, the
largest ulcer was <8 mm3 (ie, ≈2 mm wide by 2 mm long×2
mm deep), and most were <4 mm3 (ie, ≈2 mm wide by 2 mm
long×1 mm deep). As shown in Figure II in the online-only
Data Supplement, patients with TUV ≥5 mm3 and a mean total
plaque area of 266 mm2 (2.66 cm2) as shown in Table 1 would
have total plaque volumes of <400 mm3, so they would have
ample plaque to accommodate ulcers of that size.
In view of the small size of our study, validation will be
required by other groups and in larger numbers of patients. It
would be useful to know whether large ulcers on 1 side predict
ipsilateral stroke or TIA.
It seems likely that the presence of a large volume ulceration may be useful in identifying which patients with asymptomatic carotid stenosis and which patients with symptomatic
stenosis <60% to 70% might benefit from endarterectomy or
stenting. It is also possible that ulceration might represent a
therapeutic target in the management of high-risk patients and
in the evaluation of new therapies for atherosclerosis.

Conclusions
Carotid TUV predicts higher risk of cardiovascular events. In
addition to identifying high-risk patients who would warrant
more intensive medical therapy, a high ulcer volume may help
in identifying which patients with carotid stenosis might benefit from endarterectomy or stenting.
Figure 3. Kaplan–Meier survival analysis curves for participants
with total ulcer volume (TUV) ≥5.00 mm3 and those with no
ulcerations or TUV <5 mm3. Time is shown in days until the first
occurrence of any of the following events: stroke, transient ischemic attack (TIA), or cardiovascular death during the duration of
follow-up; log-rank P=0.009.
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